Get notified when LAB files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Dissolution and Liquidation (new) — The company explicitly contemplates dissolution and liquidation if the merger fails, signaling a possible loss of all or a significant portion of stockholder investment.
  • Partial Clinical Hold (new) — A partial clinical hold was placed on TLN-254 trials in June 2026 and removed in July 2026, indicating regulatory scrutiny and potential delays.
  • Withdrawn From the Market (new) — A marketed drug in the same class as TLN-254 was withdrawn due to safety concerns, raising class-wide regulatory risk for Treeline's candidate.
  • Wuxi Apptec (new) — Treeline relies on WuXi Apptec, a Chinese CDMO designated on the U.S. DoD 1260H List, creating supply-chain and regulatory risk.
NASDAQ: LAB STANDARD BIOTOOLS INC. 424B3

Standard BioTools to merge with Treeline Biosciences in all-stock deal, issuing up to 537.7M shares

Filed October 21, 2026 · ~2 min read

Key Changes

  • high

    The merger is an all-stock transaction; Treeline stockholders will own ~84% of the combined company, leaving Standard BioTools holders with ~16%.

    Prospectus Summary verify on EDGAR →
  • high

    Treeline has never generated product revenue and reported net losses of $105.5M for H1 2026 and $162.5M for 2025.

    Prospectus Summary verify on EDGAR →
  • high

    Standard BioTools must divest its mass cytometry and microfluidics businesses; mass cytometry is being agreed to sell to Element for $5.5M.

    Prospectus Summary verify on EDGAR →

3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (EPM 10-K) is open in full — no account needed.

Partner

Trade LAB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Oct 21, 2026 · How we verify